Advances / Research
Expecting Success is an initiative of the Robert Wood Johnson Foundation aimed at improving cardiac care for racial and ethnic minority populations in the United States.
Cardiovascular disease (CVD) is the number one killer of women in the United States. Long thought of as primarily affecting men, we now know that CVD—including heart disease, hypertension, and stroke—also affects a substantial number of women. Experts estimate that one in two women will die of heart disease or stroke, compared with one in 25 women who will die of breast cancer.
Edwards Lifesciences is proud to announce the acquisition of CardioVations, the recognized leader in minimally invasive valve surgery systems. With a full line of catheters, cannulae and Precision Series surgical instruments, CardioVations PORT ACCESS systems provide surgeons a pathway to their MIS future.
Not only does Alta Bates Summit Medical Center perform more cardiac surgeries than any other hospital in the Bay Area, it's also one of the top three cardiac surgery programs in the State. This year, Alta Bates Summit was once again recognized for better than expected outcomes in heart bypass surgery by the Office of Statewide Health Planning and Development.
The book is based on a joint symposium organized by the Departments of Cardiology, Diagnostic Radiology and Nuclear Medicine of the University Hospital Leiden and the Cleveland Clinical International Center. Both centers have a long-standing reputation in the various aspects of cardiac imaging techniques and in their clinical applications.
Several new studies on genetics and stem cell research, along with studies that continue to debate the use of stents to clear coronary artery blockages, are among the top research advances in heart disease and stroke.
We offer a full range of services from primary care to advanced critical care and have multiple service locations. Always mindful of our responsibility to the community, Bronson provides more than $48 million in community benefits annually through outreach and charitable care for the un- and under-insured.
Cardiac Care Critique is dedicated to providing you with the latest advances in cardiac care. As part of that effort, Cardiac Care Critique provides links to products that will help doctors learn the latest procedures and patients receive the best possible care.
Cardiothoracic and Vascular Surgical Associates is always on the cutting edge of technology and medical breakthroughs, especially concerning new advances in heart surgery. Some recent new advances have been made in heart surgery we thought you should know about.
The Cleveland Clinic Heart and Vascular Institute continues to apply new techniques, new technologies, and new research to heart disease and its treatment.
TMR is a treatment aimed at improving blood flow to areas of the heart that were not treated by angioplasty or surgery. A special carbon dioxide (CO2) laser is used to create small channels in the heart muscle, improving blood flow in the heart.
The trend in cardiac surgery is to minimize surgical trauma while reducing the incidence of perioperative morbidity. The goal is to return patients to functional levels as quickly as possible after surgery. Minimally invasive techniques have been introduced to fulfill such expectations. In coronary artery surgery, the use of smaller surgical incisions is becoming standard practice.
The Genesis Heart Institute is an evolving organization comprised of the many cardiovascular providers in the Eastern Iowa-Western Illinois Region. The Institute plays a key role in developing the solid base of clinical outcome information stored in a comprehensive cardiac clinical data base. It facilitates access to the most advanced devices, drugs, and treatment protocols through its ever-expanding research organization.
Usually, CABG is performed while the heart is temporarily stopped. During this period, its function is performed by the "Heart and Lung machine" ... a technique called cardiopulmonary bypass. This produces certain unavoidable ill-effects.
Technology and expertise have today developed to such an extent that surgeons can sometimes carry out the bypass operation even while the heart is beating. Since the heart and lung machine is no longer needed, the side effects are less.
When patients suffer from angina (chest pain) as related to their coronary artery disease they have a number of treatment modalities available to them. Often times the specific circumstance of that patient’s condition governs which modality will be chosen. Most patients respond well to medical management, percutaneous coronary intervention (angioplasty/stenting) or coronary artery bypass grafting.
Today, the MMRL is rapidly becoming an international center for genetic screening of cardiac diseases, especially those involving cardiac arrhythmias. The MMRL is also leading the way in the development of innovative and effective pharmacologic treatment for Atrial Fibrillation, one of the greatest unmet medical needs in our society today.
Gene therapy designed to grow new blood vessels in the heart muscle led the list of the top 10 research advances in heart disease and stroke compiled by the American Heart Association.
Advances in diagnosis, medical therapy and coronary intervention in patients with cardiovascular problems were highlighted in three studies expected to be presented today at the American College of Cardiology's Innovation in Intervention.
Through weekly news reports, quarterly reports, online databases, and Internet news delivery services, NewsRx produces business and consumer information relating to drugs, chemicals, biotechnology, science, medicine, and health. Known for its roster of highly respected reports, NewsRx delivers over 5,000 issues annually consisting of over 45,000 pages with over 500,000 articles per year.
NitroMed is an emerging pharmaceutical company focused on the research, development and commercialization of proprietary pharmaceuticals based on the therapeutic benefits of the naturally occurring molecule nitric oxide. The goal is to become a leading, multi-product pharmaceutical company by developing innovative nitric oxide products.
Pages: 1 
2
2
